A comparative study of non-myeloablative and myeloablative allogeneic haematopoietic stem cell transplantation in the chronic myeloid leukaemia

被引：0

作者：

Ahmed-Nacer, R ^{[1
]}

Benakli, M ^{[1
]}

Hamladji, RM ^{[1
]}

Talbi, AA ^{[1
]}

Mehdid, F ^{[1
]}

Belhadj, R ^{[1
]}

Pierre, KB ^{[1
]}

Curie, M ^{[1
]}

机构：

[1] Pierre & Marie Curie Ctr, Algiers, Algeria

来源：

BONE MARROW TRANSPLANTATION | 2005年 / 35卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S233 / S233

页数：1

共 50 条

[21] Non-myeloablative stem cell transplantation in adult acute lymphoblastic leukaemia [J].

Arnold, R ;

Lutz, C ;

Neuburger, S ;

Tamm, I ;

Dörken, B ;

Nagy, M .

BONE MARROW TRANSPLANTATION, 2005, 35 :S204-S204

[22] The impact of non-myeloablative conditioning on the outcome of allogeneic stem cell transplantation for chronic lymphocytic leukaemia: a retrospective study by the EBMT CLWP [J].

Dreger, P ;

van Biezen, A ;

Brand, R ;

Esteve, J ;

Martino, R ;

Deliliers, GL ;

Hansz, J ;

Finke, J ;

Kimby, E ;

Milligan, D ;

Michallet, M ;

Niederwieser, D .

BONE MARROW TRANSPLANTATION, 2004, 33 :S28-S29

[23] Optimisation of recombinant human erythropoietin therapy after non-myeloablative allogeneic haematopoietic stem cell transplantation [J].

Baron, F ;

Vanstraelen, G ;

Frere, P ;

Fillet, G ;

Beguin, Y .

BONE MARROW TRANSPLANTATION, 2004, 33 :S111-S111

[24] Allogeneic non-myeloablative stem cell transplantation for refractory rheumatoid arthritis [J].

Burt, R ;

Oyama, Y ;

Barr, W ;

Traynor, A .

BONE MARROW TRANSPLANTATION, 2003, 31 :S145-S146

[25] Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation [J].

Graef, Thorsten ;

Vaupel, Matthias ;

Fenk, Roland ;

Ruf, Leilan ;

Zohren, Fabian ;

Germing, Ulrich ;

Haas, Rainer ;

Kobbe, Guido .

HEMATOLOGICAL ONCOLOGY, 2007, 25 (04) :170-177

[26] Allogeneic stem cell transplantation using non-myeloablative transplant regimens [J].

Körbling, M ;

Khouri, I .

HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, :175-184

[27] SUCCESSFUL OUTCOME AFTER NON-MYELOABLATIVE ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RENAL DYSFUNCTION [J].

Kersting, S. ;

Verdonck, L. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 :141-141

[28] The role of allogeneic hematopoietic cell transplantation with non-myeloablative conditioning in chronic myeloid leukemia. [J].

Gurman, G ;

Arat, M ;

Soydan, E ;

Dalva, K ;

Ilhan, O ;

Uysal, A ;

Beksac, M .

BLOOD, 2001, 98 (11) :375B-376B

[29] The frequency of early complications after non-myeloablative haematopoietic stem cell transplantation [J].

Abdoulkadirov, K ;

Golovchenko, R ;

Nuyya, M ;

Moiseev, S .

BONE MARROW TRANSPLANTATION, 2004, 33 :S327-S327

[30] Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis [J].

Statkute, L. ;

Oyama, Y. ;

Barr, W. G. ;

Sufit, R. ;

Ho, S. ;

Verda, L. ;

Loh, Y. ;

Yaung, K. ;

Quigley, K. ;

Burt, R. K. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) :991-997

← 1 2 3 4 5 →